drugset / Trial / NCT01678677
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the safety, reactogenicity and immunogenicity of 8 different formulations of investigational NTHI vaccine in current and former smokers, 50-70 years of age.
Timeline
- Start
- 2012-08-31
- Primary completion
- 2014-01-30
- Completion
- 2014-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK2838500A | Vaccine | — | Intramuscular |
| Subject | GSK2838501A | Vaccine | — | Intramuscular |
| Subject | GSK2838502A | Vaccine | — | Intramuscular |
| Subject | GSK2838503A | Vaccine | — | Intramuscular |
| Subject | GSK2838504A | Vaccine | — | Intramuscular |
| Subject | GSK2838505A | Vaccine | — | Intramuscular |
| Subject | GSK2838508A | Vaccine | — | Intramuscular |
| Subject | GSK2838509A | Vaccine | — | Intramuscular |